Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Jan 15;1812(4):480–487. doi: 10.1016/j.bbadis.2011.01.005

Table 1.

Demographic information of AD and MCI subjects and age-matched controls. The value reported are the average of 6 samples.

Age
(years)
Sex Brain Weight
(grams)
PMI
(hours)
Braak
stage
Control (AD) 81
(72–87)
5M,1F 1219
(1020–1410)
2.00–3.75 1–3
AD 85
(80–92)
2M,4F 1104
(835–1260)
2.00–5.75 5–6
Control (MCI) 82
(74–93)
4F,2M 1204
(1080–1315)
1.75–4.00 1–2
MCI 89
(82–99)
4F,2M 1102
(930–1200)
2.00–5.00 3–5

AD, Alzheimer disease; MCI, mild cognitive impairment; PMI, post-mortem interval

HHS Vulnerability Disclosure